A wrong resistor in a circuit box created the implantable pacemaker
In 1958, American engineer Wilson Greatbatch was building an electronic oscillator to record human heart sounds at the University of Buffalo. Reaching into a tackle box of parts, he accidentally grabbed a 1-megohm resistor instead of a 10,000-ohm one. Installed in the circuit, it pulsed electricity for 1.8 milliseconds and paused for a second before pulsing again—a rhythmic beat that perfectly mimicked a human heartbeat and inspired the first practical implantable cardiac pacemaker.
An Accidental Pulse in the Workshop
In the spring of 1958, Wilson Greatbatch was working in a barn-turned-workshop behind his home in Clarence, New York, while serving on the faculty of the University of Buffalo. As an electrical engineer, he was constructing a monitoring device intended to record fast heart sounds. The device required an electronic oscillator that could produce a steady, high-frequency signal to benchmark audio recordings from the cardiovascular system.
While reaching into a tackle box filled with electrical components, Greatbatch picked up a resistor by mistake. Instead of grabbing a 10,000-ohm resistor specified for the circuit, he inserted a 1-megohm resistor—one hundred times the resistance he intended to install. When he plugged the breadboard circuit in, it did not emit the expected continuous hum. Instead, the circuit emitted a distinct electrical pulse for 1.8 milliseconds, dropped completely silent for roughly one second, and then pulsed again.
To another engineer, the misbehaving component might have been discarded as a wiring error. But Greatbatch had spent years speaking with physicians and surgeons about the mechanics of the heart. Watching the periodic discharge on his instruments, he recognized that the electrical waveform was identical to the biological timing required to stimulate cardiac muscle. Rather than correcting the mistake to resume work on his recording tool, he pivoted to an entirely different problem: building a device small enough to be placed inside the human body to regulate failing hearts.
The Danger of the Tethered Heart
In the late 1950s, electrical pacing of the human heart was already an established medical concept, but it was fraught with severe physical limitations. Early external pacemakers, such as those pioneered earlier in the decade, were large consoles that relied on wall power. Patients were tethered to machines by electrical cords, leaving them vulnerable to wall-outlet power failures or accidental disconnections. During a major blackout, an external pacemaker could cut out entirely, leaving a heart in complete block without stimulation.
Wearable, battery-operated external pacemakers had begun to emerge, but they still required wires that penetrated through the patient's skin to reach the heart muscle. These transcutaneous wires served as a direct pathway for bacteria, leading to chronic infections at the entry site. The wires were also prone to physical breakage from the patient's daily movements, requiring frequent surgical intervention to replace fractured leads.
An implantable device would eliminate the open pathway for bacteria and prevent external cords from snagging or pulling loose. However, clinical researchers were largely skeptical that a self-contained device could be made small, reliable, and durable enough to operate inside the warm, corrosive saline environment of the human body.
How the Wrong Resistor Changed the Timing
The electronic behavior Greatbatch observed was governed by basic timing characteristics in resistor-capacitor circuits, often called RC circuits. In an oscillator, a capacitor stores an electrical charge, which then discharges through a resistor. The values of both the resistor and the capacitor dictate the duration of this cycle. When a low-resistance path is provided, the charge drains rapidly, allowing the circuit to oscillate back and forth at frequencies suitable for radio or audio equipment.
By inserting a 1-megohm resistor into the feedback loop, Greatbatch dramatically throttled the flow of current. The massive resistance meant that after the initial electrical discharge, the capacitor took a full second to recharge and trigger the next state change. The active phase lasted only a fraction of that time—1.8 milliseconds—creating an asymmetrical cycle of a quick pulse followed by a long resting interval.
This duty cycle was critical. Biological heart tissue cannot tolerate continuous stimulation; cardiac muscle contracts in response to an electrical spike and requires an absolute refractory period to repolarize and refill the chambers with blood before the next beat. The 1.8-millisecond burst was sufficient to depolarize the myocardium without delivering unnecessary energy that would heat tissue, drain battery reserves, or cause ventricular arrhythmias.
Moving from Benchtop to Living Tissue
Recognizing the clinical potential of his circuit, Greatbatch sought out medical collaborators to test the concept on living tissue. He connected with Dr. William Chardack, the chief of surgery at the Buffalo Veterans Administration Hospital, and Dr. Andrew Gage. When Greatbatch presented his compact transistorized oscillator to Chardack, the surgeon was initially skeptical but agreed to an animal trial.
On May 7, 1958, the team tested an experimental prototype in an anesthetized dog. When Greatbatch touched the device's output leads to the animal's heart muscle, the ventricular contractions synchronized immediately with the synthetic pulses. Chardack looked up from the surgical field and confirmed that the device was completely driving the rhythm.
Before the device could be placed inside a human, Greatbatch had to solve the problem of biological isolation. Transistors and wiring corrode rapidly when exposed to body fluids, and moisture penetrating the circuit would cause catastrophic short circuits. Greatbatch addressed this by hand-soldering each component and casting the entire assembly inside a block of solid epoxy resin, creating a sealed, inert capsule capable of surviving implantation under the skin.
The First Implantation and the Power Bottleneck
In 1960, Chardack and Gage performed the first successful clinical implantation of Greatbatch's pacemaker in a 77-year-old man suffering from complete heart block. The patient lived for eighteen months following the surgery, demonstrating that a completely internal electrical system could sustain human life without external cables. In 1961, the design was licensed to the young medical device company Medtronic, forming the foundation for modern commercial cardiac pacing.
Despite its clinical success, the early implantable pacemaker had a critical weakness: its power supply. The units ran on primary mercury-zinc cells. These batteries discharged small amounts of hydrogen gas as they operated, requiring them to be vented, and their chemistry limited their functional lifespan to roughly two years. Patients faced repeated surgeries simply to replace exhausted batteries before their hearts lost electrical pacing support.
Greatbatch realized that pacing could never be truly maintenance-free until battery chemistry evolved. In the early 1970s, he turned his engineering focus entirely to energy storage, acquiring rights to a solid-state lithium-iodine battery patent and re-engineering it for medical use. The lithium-iodine cell produced no gas, could be hermetically sealed in metal cans, and lasted up to a decade, ultimately solving the final engineering bottleneck that limited the life of implantable pacemakers.
The Science of Prepared Accidents
The invention of the implantable cardiac pacemaker is frequently cited alongside penicillin and vulcanized rubber as a classic example of scientific serendipity. Yet the narrative of an accidental grab from a component box obscures the technical groundwork that made the discovery possible. Hundreds of technicians had misread color-coded resistor bands before Greatbatch, but none transformed that mistake into a lifesaving medical device.
Greatbatch was uniquely positioned at the intersection of engineering and physiology. He had spent years attending surgical procedures, studying the bioelectric potentials of living organs, and listening to clinicians describe the lethal consequences of heart block. His mental library contained the precise electrical parameters of a healthy cardiovascular rhythm.
When the incorrect resistor altered the timing of his oscillator, Greatbatch did not see an interrupted recording tool; he saw a synthetic sinus node. The wrong resistor provided the physical behavior, but it was an interdisciplinary understanding of human biology that turned a lab error into a durable standard of medical care.
Key takeaways
•A 1-megohm resistor installed by mistake in a recording circuit created a 1.8-millisecond pulse with a one-second pause, unintentionally mirroring the human cardiac rhythm.
•The breakthrough eliminated the transcutaneous wires of earlier external pacemakers, which had exposed patients to lethal infections and reliance on wall outlets.
•Encapsulating the electronics in epoxy resin protected delicate transistor components from corrosive body fluids, allowing safe internal placement.
•Greatbatch later tackled the pacemaker's primary flaw by developing the hermetically sealed lithium-iodine battery, expanding device life from two years to ten.